Skip to main content
Log in

Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Background: Hepatitis A is an enterically transmitted disease that still remains endemic in many developing countries. In some countries improvements in living conditions have recently led to changing in epidemiology of hepatitis A virus (HAV) infection. In our country there are very few reports on prevalence of HAV infection. Objective: To determine the seroprevalence of anti-HAV IgG among children visited in pediatric hospitals of Tehran, Iran. Methods: The study group included 1018 children who were 6 months – 14.9 years of age. These children were visited in four major pediatric hospitals of Tehran. The children were separated to three age groups: Group 1 (6 months–4.9 years; n = 469), Group 2 (5.0–9.9 years; n = 290), and Group 3 (10.0–14.9 years; n = 259). Serum anti-HAV IgG was tested with commercial ELISA kits. The data were tested for statistical significance with χ2 test. Results: In all subjects, seroprevalence of hepatitis A was 22.3%(95% CI: 19.7, 24.9). There was no significant difference between genders (22.2% vs. 22.5% in males and females, respectively) and among age groups (Group 1 was 22.1% and Group 3 was 25.9; p > 0.05). Conclusions: In summary, it seems that HAV infection is not highly endemic at least in some urban areas of Iran. On the basis of this epidemiologic data, post exposure prophylaxis would be necessary for children and young adults, and hepatitis A vaccination strategy should be revised.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Koff RS. Hepatitis A. Lancet 1998; 351: 1643-1649.

    Google Scholar 

  2. Feinstone SM. Hepatitis A: Epidemiology and prevention. Eur J Gastroentrol Hepatol 1996; 8: 300-305.

    Google Scholar 

  3. Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10(Suppl 1): S63-S66.

    Google Scholar 

  4. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis 1995; 171(Suppl 1): S2-S8.

    Google Scholar 

  5. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992; 10(Suppl 1): S56-S58.

    Google Scholar 

  6. Werner GT, Frosner GG, Fresenius K. Prevalence of serological hepatitis A and B markers in a rural area of northern Zaire. Am J Trop Med Hyg 1985;34: 620-624.

    Google Scholar 

  7. Tsega E, Nordenfeldt E, Mengesha B, et al. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children. Scand J Infect Dis 1990; 22: 145-148.

    Google Scholar 

  8. Arankalle VA, Tesarev SA, Chandha M, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India 1982 and 1992. J Infect Dis 1995; 171: 447-450.

    Google Scholar 

  9. Joshi N, Yr NK, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus Heydarabad, India. Trop Gastroenterol 2000; 21: 63-65.

    Google Scholar 

  10. Sawayama Y, Hayashi J, Ariyama I, et al. A ten year serological survey of hepatitis A, B, and C viruses infections in Nepal. J Epidemiol 1999; 9: 350-354.

    Google Scholar 

  11. Kunasol P, Cooksley G, Chan VF, et al. Hepatitis A virus: Declining seroprevalence in children and adolescents in Southeast Asia. Southeast Asian J Trop Med Publ Hlth 1998; 29: 255-262.

    Google Scholar 

  12. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18: S57-S60.

    Google Scholar 

  13. Perez OM, Morales W, Paniagua M, Strannegard O. Prevalence of hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua. Am J Trop Med Hyg 1996; 55: 17-21.

    Google Scholar 

  14. Shapiro CN, Coleman PJ, McQuillen GM, Alter MJ, Margolis HS. Epidemiology of Hepatitis A: Seroepidemiology and risk groups in the USA. Vaccine 1992; 10(Suppl 1): S59-S62.

    Google Scholar 

  15. Weiland O, Berg R, Bottiger M, Lundbergh P. Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community. Scand J Infect Dis 1980; 12: 171-174.

    Google Scholar 

  16. Siebke J, Degre M, Ritland S, Enger S. Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway. Am J Epidemiol 1982; 115: 185-191.

    Google Scholar 

  17. Dal-Re R, Garcia-Corbeira P, Garcia-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. J Med Virol 2000; 60: 363-366.

    Google Scholar 

  18. Marinho RT, Valente AR, Ramalho FJ, de Moura MC. The changing epidemiological pattern of hepatitis A in Lisbon, Portugal. Eur J Gastroentrol Hepatol 1997; 9: 795-797.

    Google Scholar 

  19. Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E. Prevalence of Hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol 1997; 13: 417-420.

    Google Scholar 

  20. Panchareon C, Mekmullica J, Kasempimolporn S, Thisyakorn U, Wilde H. Seroprevalence of hepatitis A virus antibody among children and young adult in Bangkok. J Med Assoc Thai 2001; 84: 1477-1480.

    Google Scholar 

  21. Ripabelli G, Sammarco ML, Campo T, Montanaro C, D'Ascenzo E, Grasso GM. Prevalence of antibodies against enterically transmitted viral hepatitis (HAV and HEV) among adolescents in an inland territory of central Italy. Eur J Epidemiol 1997; 13: 45-47.

    Google Scholar 

  22. Yassin K, Awad R, Tebi A, Queder A, Lasser U. The epidemiology of hepatitis A infection in Palestine: A universal vaccination programme is not yet needed. Epidemiol Infect 2001; 127: 335-339.

    Google Scholar 

  23. Antaki N, Kebbewar MK. Hepatitis A seroprevalence rate in Syria. Trop Doct 2000; 30: 99-101.

    Google Scholar 

  24. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000; 18(Suppl 1): S65-S67.

    Google Scholar 

  25. Management and Planning Organization (I.R.I). Iran Statistical Year Book. Tehran: The Organization, 2001.

    Google Scholar 

  26. el-Hazmi MA. Hepatitis A antibodies: Prevalence in Saudi Arabia. J Trop Med Hyg 1989; 92: 427-430.

    Google Scholar 

  27. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S. Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17: 141-144.

    Google Scholar 

  28. Colak D, Ogunc D, Gunseren F, Velipasaoglu S, Aktekin MR, Gultekin M. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey. Acta Microb Immunol Hung 2002; 49: 93-97.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Jafari Mehr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jafari Mehr, A., Ehsani Ardakani, M.J., Hedayati, M. et al. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol 19, 275–278 (2004). https://doi.org/10.1023/B:EJEP.0000020345.37091.cd

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:EJEP.0000020345.37091.cd

Navigation